Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FL.4.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FQ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JB.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.3.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FZ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.7.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.30.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.68EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CD.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.122.3 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.41EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CA.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BH.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BL.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BS.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.13.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DC.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CP.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EQ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JU.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CJ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BM.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DE.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.75.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.51EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.132 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.1.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KF.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CS.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.83EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BJ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDGEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used